Advisor Resource Council Purchases New Stake in CVS Health Corporation (NYSE:CVS)

Advisor Resource Council purchased a new stake in CVS Health Corporation (NYSE:CVS - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 17,235 shares of the pharmacy operator's stock, valued at approximately $1,150,000.

Several other hedge funds have also bought and sold shares of CVS. LaFleur & Godfrey LLC grew its position in CVS Health by 49.9% in the 4th quarter. LaFleur & Godfrey LLC now owns 4,836 shares of the pharmacy operator's stock valued at $217,000 after purchasing an additional 1,610 shares during the period. Atria Wealth Solutions Inc. boosted its holdings in CVS Health by 62.3% during the 4th quarter. Atria Wealth Solutions Inc. now owns 62,160 shares of the pharmacy operator's stock worth $2,790,000 after acquiring an additional 23,849 shares during the last quarter. Handelsbanken Fonder AB boosted its holdings in CVS Health by 3.6% during the 4th quarter. Handelsbanken Fonder AB now owns 603,225 shares of the pharmacy operator's stock worth $27,079,000 after acquiring an additional 20,955 shares during the last quarter. Cromwell Holdings LLC purchased a new position in CVS Health during the 4th quarter worth $117,000. Finally, Compass Planning Associates Inc purchased a new position in CVS Health during the 4th quarter worth $37,000. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the business's stock in a transaction dated Thursday, June 5th. The stock was bought at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the acquisition, the director now owns 12,007 shares of the company's stock, valued at $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 1.22% of the company's stock.

CVS Health Trading Down 0.2%

Shares of CVS Health stock opened at $66.69 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. The stock has a market capitalization of $84.36 billion, a P/E ratio of 15.92, a P/E/G ratio of 0.96 and a beta of 0.56. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $72.51. The stock's 50-day simple moving average is $64.92 and its 200 day simple moving average is $60.40.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The business had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.31 EPS. As a group, research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have issued reports on CVS. UBS Group lifted their price objective on shares of CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. Piper Sandler lifted their price objective on shares of CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a report on Friday, March 21st. Royal Bank Of Canada lifted their price objective on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Robert W. Baird lifted their target price on CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Finally, Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $74.75.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.